The Nucleic Acid Therapeutics Initiative (NATi) is a national platform that aims to build Singapore into a regional hub for nucleic acid therapeutics (NAT) research, clinical translation, and commercialisation.
NATi harnesses the potential of nucleic acids to treat diseases using RNA molecules. This initiative bolsters strategic partnerships and propels healthcare innovations, benefiting Singapore and Singaporeans.